AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group (Q84567924)
Jump to navigation
Jump to search
scientific article published on 15 July 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group |
scientific article published on 15 July 2011 |
Statements
AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group (English)
Todd M Cooper
Janet Franklin
Robert B Gerbing
Todd A Alonzo
Craig Hurwitz
Susana C Raimondi
Betsy Hirsch
Franklin O Smith
Prasad Mathew
Robert J Arceci
Robert Iannone
Robert S Lavey
Soheil Meshinchi